TABLE 3.
Participant Need Variables | All Participants With Eye Disease (N = 3349) |
Previously Detected Eye Disease N = 1254 (37.4%) |
Undetected Eye Disease N = 2095 (62.6%) |
P* |
---|---|---|---|---|
History of diabetes | <0.0001 | |||
No | 2539 (75.9) | 1094 (87.3) | 1445 (69.0) | |
Yes | 807 (24.1) | 159 (12.7) | 648 (31.0) | |
History of hypertension | 0.0001 | |||
No | 2112 (63.2) | 843 (67.3) | 1269 (60.8) | |
Yes | 1228 (36.8) | 409 (32.7) | 819 (39.2) | |
Comorbidities† | <0.0001 | |||
<2 | 1657 (49.5) | 714 (57.0) | 943 (45.1) | |
≥2 | 1689 (50.5) | 539 (43.0) | 1150 (54.9) | |
General health | <0.0001 | |||
Excellent/very good | 578 (17.3) | 264 (21.1) | 314 (15.0) | |
Good/fair/poor | 2768 (82.7) | 989 (78.9) | 1779 (85.0) | |
General vision | <0.0001 | |||
Excellent/good | 1320 (39.6) | 552 (44.1) | 768 (36.9) | |
Fair/poor/very poor/blind | 2017 (60.4) | 701 (55.9) | 1316 (63.1) |
Data are presented as frequency (%) based on column totals. The total number of participants for each item varies depending on completion rates for the item.
P values were calculated using χ2 tests.
Number of self-reported comorbidities (arthritis, stroke/brain hemorrhage, high blood pressure, angina, heart attack, heart failure, asthma, skin cancer, other cancer, back problems, hearing problems, and other major health problems).